ArticleClinical and experimental hepatology2023

Assessment of serum CXCL9 and pentraxin 3 as novel markers for hepatocellular carcinoma in cirrhotic hepatitis C patients.

Rafik Gabbour Mehanna et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.